Accueil › Leucémie myéloïde chronique › Texas › Houston
Essais cliniques pour Leucémie myéloïde chronique à Houston, TX
18 études pour Leucémie myéloïde chronique recherchent des participants dans et autour de Houston (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- UT MD Anderson Cancer Center, Houston
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Recrutement en coursÉtude observationnelle
- Texas Children's Hospital, Houston
Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib
Recrutement en coursPhase 2
- MD Anderson Cancer Center, Houston
Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
Recrutement en coursPhase 2
- The University of Texas M. D. Anderson Cancer Center, Houston
Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
Recrutement en coursPhase 2
- MD Anderson Cancer Center, Houston
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
Recrutement en coursPhase 1
- M D Anderson Cancer Center, Houston
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
Recrutement en coursPhase 2
- M D Anderson Cancer Center, Houston
Study of Olverembatinib (HQP1351) in Patients With CML-CP
Recrutement en coursPhase 3
- Ascentage Investigative Site #1501, Houston
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Recrutement en coursÉtude observationnelle
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital - Baylor Medical Center, Houston
Asciminib Roll-over Study
Recrutement en coursPhase 4
- Uni Of TX MD Anderson Cancer Cntr, Houston
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
Recrutement en coursPhase 2
- M D Anderson Cancer Center, Houston
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Recrutement en coursÉtude observationnelle
- University of Texas MD Anderson Cancer Center, Houston
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
Recrutement en coursPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Recrutement en coursPhase 2
- MD Anderson, Houston
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Recrutement en coursPhase 1
- MD Anderson Cancer Center, Houston
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
Recrutement en coursPhase 1/2
- The University of Texas M.D. Anderson Cancer Center, Houston
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
Recrutement en coursPhase 1
- University of Texas MD Anderson Cancer Center, Houston
TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia
Recrutement en coursPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
Essais pour Leucémie myéloïde chronique dans d'autres villes
- Seattle, WA11 études
- New York City, NY11 études
- Birmingham, AL6 études
- Detroit, MI6 études
- Chicago, IL6 études
- Portland, OR6 études
- Philadelphia, PA6 études
- Baldwin Park, CA6 études
- Nashville, TN5 études
- Columbus, OH5 études
- Boston, MA5 études
- Atlanta, GA5 études
Autres études à Houston
- Cancer du poumon non à petites cellules145 études
- Cancer du sein126 études
- Cancer (tous types)121 études
- Cancer métastatique104 études
- Cancer colorectal102 études
- Cancer de l'ovaire89 études
- Leucémie aiguë myéloïde85 études
- Cancer du poumon78 études
- Cancer de la prostate76 études
- Cancer de l'endomètre68 études
- Cancer du pancréas61 études
- Mélanome59 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.